Correspondence: Seppo Heinonen, seppo.heinonen@kuh.fi
IntroductionPostoperative morbidity and mortality, especially in cancer patients, have been reviewed in a number of studies in the field of gynecology [1][2][3]. Morbidity after gynaecological surgery ranges from approximately 10% to 20%, whereas mortality is extremely rare [4][5][6]. Clinical guidelines and recommendations based on the unusual events of patient death are of little importance in medical care of the general population, and therefore information on severe acute morbidity as evidenced by near-miss cases and utilisation of intensive care units (ICUs) may help to audit the quality of care in a more meaningful manner. Reports on the utilisation and outcomes of critical care services required in the management of all gynaecological patients are rare. The other side of the coin is that severe morbidity and the need for intensive care poorly reflect the long-term effects leading to mortality after discharge from hospital. As far as we are aware, studies of the need for intensive care in gynaecology have not been recently conducted in the Nordic countries, where patient care is organised by public health care units, and thus virtually all women receive modern care. This study was undertaken to APACHE II = Acute Physiological and Chronic Health Evaluation II; ICU = intensive care unit; IVF = in vitro fertilisation; TISS = Therapeutic Intervention Scoring System.
AbstractIntroduction The purpose of this study was to note potential gynaecological risk factors leading to intensive care and to estimate the frequency, costs and outcome of management.
Materials and methodsIn a cross-sectional study of intensive care admissions in Kuopio from March 1993 to December 2000, 23 consecutive gynaecological patients admitted to a mixed medicalsurgical intensive care unit (ICU) were followed. We recorded demographics, admitting diagnoses, scores on the Acute Physiological and Chronic Health Evaluation (APACHE) II, clinical outcome and treatment costs. Results The overall need for intensive care was 2.3 per 1000 women undergoing major surgery during the study period. Patients were 55.4 ± 16.9 (mean ± SD) years old, with a mean APACHE II score of 14.07 (± 5.57). The most common diagnoses at admission were postoperative haemorrhage (43%), infection (39%) and cardiovascular disease (30%). The duration of stay in the ICU was 4.97 (± 9.28) (range 1-42 ) days and the mortality within 6 months was 26%, although the mortality in the ICU was 0%. The total cost of intensive care was approximately US$7044 per patient. Conclusions Very few gynaecological patients develop complications requiring intensive care. The presence of gynaecological malignancy and pre-existing medical disorders are clinically useful predictors of eventual outcome, but many cases occur in women with a low risk and this implies that the risk is relevant to all procedures. Further research is needed to determine effective preventive approaches.